CXCL8 and colorectal cancer: In conclusion, this study is the first to demonstrate that IL-8 can be routinely assessed using standardized methods during preoperative blood sampling and may serve as a valuable tool to predict overall survival in patients undergoing liver surgery for metastasized colorectal cancer.